LU83869A1 - Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine - Google Patents

Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine Download PDF

Info

Publication number
LU83869A1
LU83869A1 LU83869A LU83869A LU83869A1 LU 83869 A1 LU83869 A1 LU 83869A1 LU 83869 A LU83869 A LU 83869A LU 83869 A LU83869 A LU 83869A LU 83869 A1 LU83869 A1 LU 83869A1
Authority
LU
Luxembourg
Prior art keywords
gamma
carnitine
butyrobetaine
patients
treatment
Prior art date
Application number
LU83869A
Other languages
English (en)
French (fr)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of LU83869A1 publication Critical patent/LU83869A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU83869A 1981-01-06 1982-01-06 Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine LU83869A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4751881 1981-01-06
IT47518/81A IT1198434B (it) 1981-01-06 1981-01-06 Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina

Publications (1)

Publication Number Publication Date
LU83869A1 true LU83869A1 (fr) 1982-05-07

Family

ID=11260827

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83869A LU83869A1 (fr) 1981-01-06 1982-01-06 Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine

Country Status (15)

Country Link
US (1) US4382092A (it)
JP (1) JPS57136516A (it)
AU (1) AU548787B2 (it)
BE (1) BE891639A (it)
CH (1) CH649218A5 (it)
DE (1) DE3200016A1 (it)
FR (1) FR2497510B1 (it)
GB (1) GB2091101B (it)
GR (1) GR75132B (it)
IE (1) IE52404B1 (it)
IL (1) IL64632A0 (it)
IT (1) IT1198434B (it)
LU (1) LU83869A1 (it)
NL (1) NL8200022A (it)
SE (1) SE453569B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
IT1219448B (it) * 1988-02-12 1990-05-18 Sigma Tau Ind Farmaceuti Alimento per animali domestici carnivori, in particolare per cani integrato con l-carnitina
US5240961A (en) * 1992-07-02 1993-08-31 Shug Austin L Method of treating reduced insulin-like growth factor and bone loss associated with aging
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
JP2553013B2 (ja) * 1993-07-19 1996-11-13 ヤマハ発動機株式会社 燃料噴射式エンジンの吸気装置
US5569457A (en) * 1994-11-18 1996-10-29 Shug; Austin L. Method of stimulating antibody formation
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
KR100411275B1 (ko) * 1999-09-15 2003-12-18 주식회사 포스코 언로더 코일 적치위치 제어장치
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
DE3200016C2 (it) 1992-12-03
JPS57136516A (en) 1982-08-23
US4382092A (en) 1983-05-03
CH649218A5 (it) 1985-05-15
AU548787B2 (en) 1986-01-02
FR2497510B1 (fr) 1986-04-25
SE453569B (sv) 1988-02-15
GB2091101B (en) 1985-02-20
GB2091101A (en) 1982-07-28
IT1198434B (it) 1988-12-21
FR2497510A1 (fr) 1982-07-09
NL8200022A (nl) 1982-08-02
IL64632A0 (en) 1982-03-31
DE3200016A1 (de) 1982-08-12
JPH0424325B2 (it) 1992-04-24
IE52404B1 (en) 1987-10-14
GR75132B (it) 1984-07-13
SE8200007L (sv) 1982-07-07
AU7908781A (en) 1982-07-15
IE813099L (en) 1982-07-06
IT8147518A0 (it) 1981-01-06
BE891639A (fr) 1982-04-16

Similar Documents

Publication Publication Date Title
US4970076A (en) Fatty acid composition
EP0195570B1 (en) Pharmaceutical compositions
LU83869A1 (fr) Procede de preparation d'une composition pharmaceutique comprenant de la gamma-butyrobetaine pour le traitement de syndromes provoques par une deficience en l-carmitine
EP0457950B1 (fr) Utilisation de l'acide stéaridonique pour le traitement des maladies inflammatoires
US5240961A (en) Method of treating reduced insulin-like growth factor and bone loss associated with aging
JPH0733655A (ja) 医薬組成物
FR2774591A1 (fr) Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
FR2530468A1 (fr) Composition analgesique et anti-inflammatoire contenant de l'ibuprofen
JPH05316998A (ja) 食品組成物
AU679818B2 (en) Butyric ester cyto-differentiating agents
US7666909B2 (en) Enhancement of alcohol metabolism
FR2654931A1 (fr) Compositions pharmaceutiques possedant une activite sur l'ataxie et les troubles de l'equilibre, cerebelleux ou autres, de toutes origines, comprenant l'association de l-5-hydroxytryptophane et de carbidopa.
EP0108017B1 (fr) Association renfermant à titre de principes actifs, un analgésique central et la vitamine B12 ou un de ses analogues
FR2585953A1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
Khan-Siddiqui Lysine-carnitine conversion in rat and man
FR2515962A1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
WO2023156275A1 (en) Pharmaceutical composition and medicament comprising l-tryptophan, l-5-hydroxytryptophan and a peripheral degradation inhibitor
BE905736A (fr) Compositions pharmaceutiques comprenant du chrome destinees a etre utilisees dans le traitement de l'arteriosclerose.
BE894696A (fr) Nouveaux medicaments a base de 9,10-dihydro-ergonine pour le traitement de l'arteriosclerose